This is because such comments represent the simplest and most universally applicable form of criticism, requiring little additional insight or understanding of the specific context) To make an analogy
In this two-tier screening approach, BBB-PAMPA was first employed to eliminate compounds with poor passive permeability, followed by MDR1-MDCK I to screen out P-gp efflux transporters' substrates
although albuminuria is a clinically meaningful biomarker and treatment target, it remains a surrogate endpoint and does not, by itself, prove reduction in kidney failure or need for kidney replacement therapy
The Precision Peptide Genetic Test can reveal genetic predispositions to GLP-1 sensitivity across 14 different metabolic pathways, helping personalize your treatment selection from the start
doi: 10.1186/s13023-015-0312-z 61 RosenbergAGWPellikaanKPoitouCGoldstoneAPHybyeCMarkovicTet al
In such cases, your doctor may not prescribe Januvia for you